On December 28, 2016, Karen Barth Menzies was appointed by United States District Judge Engelhardt, of the Eastern District of Louisiana, as Co-Lead Counsel in the In re: Taxotere (Docetaxel) Products Liability Litigation.
Lawsuits Allege that Patients Suffered Permanent, Disfiguring Hair Loss from Chemotherapy Drug
Amy Zeman will attend and present at the 2016 Duke MDL Conference on October 27-28 in Arlington, Virginia. The invitation-only conference addresses emerging issues in large and mass-tort MDLs. Structured as an interactive discussion between practitioners, judges and professors, the conference is intended to lay the groundwork for the update and revision to the Duke Law Standards and Best Practices for Large and Mass-Tort MDLs. Topics to be addressed throughout the conference include:
Karen Barth Menzies will attend and present at the Mass Torts Made Perfect Conference in Las Vegas this week. Mass Torts Made Perfect is the largest gathering of mass tort attorneys in the world, and is designed to build, expand and grow the practices of attorneys in the profession.
On Thursday, September 15, 2016, Karen Barth Menzies and Andre Mura will participate in a webinar sponsored by the American Association for Justice entitled “Personal Jurisdiction in Mass Torts and Class Actions: Exploring the Impact of BMS v. Superior Court.” The webinar will analyze the impact of the California Supreme Court’s recent ruling in BMS v. Superior Court, holding that state courts have jurisdiction to hear out-of-state residents’ claims that they were injured by the Bristol-Myers Squibb blood thinner, Plavix, and how the ruling may firmly establish California’s status as a battleground for mass torts. Specifically, the webinar will address the following topics:
A.J. de Bartolomeo and Karen Barth Menzies presented at the recent “MDL Conference,” sponsored by Harris Martin Publishing. AJ presented a summary briefing on the due process requirements of class action notice and the related proposed amendments to the Federal Rule of Civil Procedure 23. Karen’s discussion highlighted cases involving proton pump inhibitor heartburn medications, such as Nexium and Prilosec.
At the recent 2016 AAJ convention, Karen Barth Menzies, was appointed to serve as Co-Chair of the Taxotere Litigation Group, which is comprised of plaintiff attorneys throughout the country representing breast cancer patients who experienced permanent hair loss following the use of the Taxotere chemotherapy product. The litigation group will allow attorneys to collaborate on the status and developments of the ongoing Taxotere lawsuits filed against manufacturer Sanofi-Aventis.
OAKLAND, CA –- Gibbs Law Group has filed a federal lawsuit against Sanofi-Aventis alleging that the company failed to warn breast cancer patients that they may experience permanent, disfiguring hair loss, or alopecia, following the use of its Taxotere (docetaxel) chemotherapy product.
A.J. de Bartolomeo presented at the Harris Martin Women’s Health Litigation Conference in Beverly Hills, California on June 22, 2016. She joined a panel of highly-regarded plaintiff’s attorneys in a discussion entitled “Plastic in the Pelvis: Essure and Mesh Litigation.” A.J. focused on the current status of the Essure litigation, specifically providing information on the Essure birth control product, description of the injuries suffered, and a litigation status update. Other topics included an array of important women’s issues such as wage inequality and the Equal Pay Act, ongoing birth control injuries and litigation, and a discussion of how pharmaceutical companies target women to sell drugs, devices, and “diseases.”